Výsledky vyhledávání - "Agnese Biagini"

Treatment of advanced thyroid cancer with targeted therapies: ten years of experience

Autor: Valeria Bottici, Luciana Puleo, Agnese Biagini, Laura Valerio, Laura Agate, Paolo Vitti, Valentina Battaglia, Carlotta Giani, Virginia Cappagli, Eleonora Molinaro, Loredana Lorusso, Salvatore Mazzeo, Rossella Elisei, Elena Sabini, Letizia Pieruzzi, David Viola, Paolo Passannati, Benedetta Pontillo-Contillo, Antonio Matrone

Publikováno v: Endocrine-Related Cancer. 23:R185-R205

Thyroid cancer is rare, but it is the most frequent endocrine malignancy. Its prognosis is generally favorable, especially in cases of well-differentiated thyroid cancers (DTCs), such as papillary and follicular cancers, which have survival rates of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a343f7e5b94831bc81f8f69b4ff4a28
https://doi.org/10.1530/erc-15-0555

Zobrazit plný text záznamu

Nuove indicazioni all’impiego del TSH umano ricombinante (rhTSH) e basse attività di 131I nella radioablazione del residuo tiroideo post-chirurgico

Autor: David Viola, Claudia Ceccarelli, Federica Brozzi, Letizia Pieruzzi, Francesca Bianchi, Rossella Elisei, Carlotta Giani, Agnese Biagini, Eleonora Molinaro, Laura Agate

Publikováno v: L'Endocrinologo. 14:255-260

L’ablazione con radioiodio (RRA) in pazienti con carcinoma differenziato della tiroide a rischio basso/intermedio e un argomento di acceso dibattito sia per l’attivita di 131I che per la modalita di preparazione [ipotiroidismo vs eutiroidismo con

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7bb8feae7eb0555ee5d2800297047f69
https://doi.org/10.1007/bf03346113

Zobrazit plný text záznamu

Patients With Differentiated Thyroid Cancer Who Underwent Radioiodine Thyroid Remnant Ablation With Low-Activity 131I After Either Recombinant Human TSH or Thyroid Hormone Therapy Withdrawal Showed the Same Outcome After a 10-Year Follow-up

Autor: Laura Agate, Paolo Vitti, Eleonora Molinaro, Federica Brozzi, Rossella Elisei, Claudia Ceccarelli, Agnese Biagini, Carlotta Giani, Furio Pacini, Letizia Pieruzzi, Francesca Bianchi, David Viola, Paolo Piaggi

Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 98:2693-2700

Background: No long-term follow-up data are available for differentiated thyroid carcinoma (DTC) patients prepared with either exogenous or endogenous TSH and treated with low-activity (1.1 GBq [30 mCi]) radioiodine (131I). Aim: The aim of this study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6adca24b01db007f5fea885425354d90
https://doi.org/10.1210/jc.2012-4137

Zobrazit plný text záznamu

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

Autor: Eleonora Molinaro, Salvatore Mazzeo, Laura Valerio, Elena Sabini, Agnese Biagini, Loredana Lorusso, Carlotta Giani, Valentina Battaglia, Paolo Passannanti, Benedetta Pontillo-Contillo, Rossella Elisei, Letizia Pieruzzi

Publikováno v: OncoTargets and therapy

Lenvatinib is a small oral molecule able to inhibit three of the extracellular and intracellular molecules involved in the modulation of angiogenesis and lymphangiogenesis: vascular endothelial growth factor receptor 1–3, fibroblast growth factor r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd129647694f5ef521b13fcd1fba0bac
http://hdl.handle.net/11568/840078

Zobrazit plný text záznamu

TheBRAFV600E Mutation Is an Independent, Poor Prognostic Factor for the Outcome of Patients with Low-Risk Intrathyroid Papillary Thyroid Carcinoma: Single-Institution Results from a Large Cohort Study

Autor: Cristiana Lupi, Riccardo Giannini, Cristina Romei, David Viola, Liborio Torregrossa, Paolo Miccoli, Agnese Biagini, Fulvio Basolo, Paolo Piaggi, Paolo Vitti, Eleonora Molinaro, Aldo Pinchera, Laura Valerio, Rossella Elisei, Clara Ugolini, Gabriele Materazzi, Laura Agate

Publikováno v: The Journal of Clinical Endocrinology & Metabolism. 97:4390-4398

The BRAF(V600E) mutation, the most frequent genetic alteration in papillary thyroid carcinoma (PTC), was demonstrated to be a poor prognostic factor. The aim of this study was to evaluate its prognostic significance in a large cohort of low-risk intr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8966db90c3ae64199b96ec9dbc04f591
https://doi.org/10.1210/jc.2012-1775

Zobrazit plný text záznamu

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

Autor: Agnese Biagini, David Viola, Paolo Passannanti, Fulvio Basolo, Aldo Pinchera, Clara Ugolini, Gabriele Materazzi, Valeria Bottici, Rossella Elisei, Barbara Cosci, Cristina Romei, G. Renzini, Paolo Vitti, Eleonora Molinaro, Laura Agate

Publikováno v: Clinical Endocrinology. 74:241-247

Summary Objective This study was aimed to demonstrate the clinical benefits of rearranged during transfection (RET) genetic screening in patients with apparently sporadic medullary thyroid cancer (MTC) not only to identify the hereditary nature of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::53dedee5d5eb20497659b334a29fa95e
https://doi.org/10.1111/j.1365-2265.2010.03900.x

Zobrazit plný text záznamu

RAI thyroid bed uptake after total thyroidectomy: A novel SPECT-CT anatomic classification system

Autor: Dipti Kamani, R. Michael Tuttle, Ravinder K. Grewal, Rebecca Zeuren, Ashok R. Shaha, Agnese Biagini, Gregory W. Randolph, Mona M. Sabra

Publikováno v: The Laryngoscope. 125(10)

Objective Recent, more selective use of radioactive iodine (RAI) has led to reevaluation of the clinical importance of achieving complete total thyroidectomy with minimal residual normal thyroid tissue. We utilize the improved localization by post-RA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::89af1edd3f800a592a87017a38143875
https://pubmed.ncbi.nlm.nih.gov/25891354

Zobrazit plný text záznamu

Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?

Autor: Liborio Torregrossa, Gabriele Materazzi, Agnese Biagini, Laura Agate, Clara Ugolini, Paolo Miccoli, Paolo Vitti, Rossella Elisei, Francesca Casella, Raffaele Ciampi, Alessia Tacito, Valeria Bottici, Eleonora Molinaro, Cristina Romei, Fulvio Basolo, David Viola, Antonio Matrone

Publikováno v: Clinical endocrinology. 82(6)

SummaryObjective Medullary thyroid carcinoma (MTC) is a rare disease that can be inherited or sporadic; its pathogenesis is related to activating mutations in the RET gene. Design This study describes our 20-year experience regarding RET genetic scre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa45040be8f22e6abace03a8087e6f01
https://pubmed.ncbi.nlm.nih.gov/25440022

Zobrazit plný text záznamu

How to manage patients with differentiated thyroid cancer and a rising serum thyroglobulin level

Autor: Agnese Biagini, David Viola, Antonio Matrone, Eleonora Molinaro, Rossella Elisei, Laura Agate

Publikováno v: Endocrinology and metabolism clinics of North America. 43(2)

Serum thyroglobulin (sTg) is the marker for monitoring persistence/recurrence of differentiated thyroid cancer, in patients without sTg antibodies. Patients with undetectable basal sTg or peak sTg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf353406bec2e74854a20473f0b0c1a
https://pubmed.ncbi.nlm.nih.gov/24891165

Zobrazit plný text záznamu

Ret Oncogene and Thyroid Carcinoma

Autor: Rossella Elisei, Raffaele Ciampi, David Viola, Alessia Tacito, Eleonora Molinaro, Antonio Matrone, A Vivaldi, Bottici, Agnese Biagini, Cristina Romei, Laura Agate

Publikováno v: Journal of Genetic Syndromes & Gene Therapy.

Thyroid cancer is a malignant neoplasm that originates from follicular or parafollicular thyroid cells and is categorized as papillary (PTC), follicular (FTC), anaplastic (ATC) or medullary thyroid carcinoma (MTC). The alteration of the Rearranged du

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93b9ed9ec43754b2218bc7fab4380516
https://doi.org/10.4172/2157-7412.1000214

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání